← Leaderboards
Charles E McKenna
University Of Southern California
$5,624,446
Attributed
$6,422,329
Total exposure
7
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $892.8K · FY2013–23$1M$750K$500K$250K$0
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
Funding mix
By agency
NIH$6,422,329 · 7
By mechanism
R01$3,014,950 · 1
R21$2,049,516 · 4
U19$1,242,579 · 1
R41$115,284 · 1
Top collaborators
- Kai Chen4 shared
- Ichiro Nishimura2 shared
- William J Britt1 shared
- Mark N Prichard1 shared
Most similar at University Of Southern California
Same institution · by research overlap
- Austin K Mircheff$4,225,296
- Joel Ernest Schechter$2,260,590
- Sarah F Hamm-Alvarez$19,612,481
Others in their field
Top investigators on “Cells”
- Lawrence Corey · Fred Hutchinson Cancer Center$536,344,731
- Barton F Haynes · Duke University$457,457,619
- David Heimbrook · Leidos Biomedical Research, Inc.$454,789,509
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$299,104,942
- Dennis R. Burton · Scripps Research Institute$278,781,854
- Mary M Horowitz · Medical College Of Wisconsin$237,383,608
Research focus
CellsDesignBaseStructureSuccessEvaluationPhysiologicalIn VitroIn VivoAnalogClinicBisphosphonateSiteCaliforniaLaboratoriesPharmacologyTrainingChemistryOralPropertyMalignant NeoplasmsResearch Project GrantsSafetyPharmaceutical Preparations
Grant awards (21)
Small Molecule Inhibitors Targeting Adenovirus$568,581
R01 · FY2023 · AI · contact PI
Novel Bisphosphonate PET Probes for Myeloma Bone Disease$188,988
R21 · FY2023 · CA
Small Molecule Inhibitors Targeting Adenovirus$572,326
R01 · FY2022 · AI · contact PI
Novel Bisphosphonate PET Probes for Myeloma Bone Disease$226,784
R21 · FY2022 · CA
Small Molecule Inhibitors Targeting Adenovirus$617,449
R01 · FY2021 · AI · contact PI
Novel Bisphosphonate PET Probes for Myeloma Bone Disease$192,844
R21 · FY2021 · CA
IMATâITCR Collaboration: Preclinical Evaluation of Novel Bisphosphonate PET Probes for Myeloma Bone Disease$82,500
R21 · FY2021 · CA
Small Molecule Inhibitors Targeting Adenovirus$601,915
R01 · FY2020 · AI · contact PI
Small Molecule Inhibitors Targeting Adenovirus$654,679
R01 · FY2019 · AI · contact PI
Mechanistic Approaches to Inhibition of Emerging DNA Viruses$198,000
R21 · FY2019 · AI · contact PI
Mechanistic Approaches to Inhibition of Emerging DNA Viruses$255,500
R21 · FY2018 · AI · contact PI
Chemical Synthesis, Biochemistry & Spectroscopic Analysis$334,856
U19 · FY2017 · CA · contact PI
Selective inhibition of fungal BET protein Bdf1$206,250
R21 · FY2017 · AI · contact PI
Selective inhibition of fungal BET protein Bdf1$247,500
R21 · FY2016 · AI · contact PI
Chemical Synthesis, Biochemistry & Spectroscopic Analysis$227,310
U19 · FY2016 · CA · contact PI
Chemical Synthesis, Biochemistry & Spectroscopic Analysis$227,310
U19 · FY2015 · CA · contact PI
Molecular and cellular mechanism of ONJ related to osteoclast inhibition$199,375
R21 · FY2015 · DE · contact PI
Molecular and cellular mechanism of ONJ related to osteoclast inhibition$251,775
R21 · FY2014 · DE · contact PI
Chemical Synthesis, Biochemistry & Spectroscopic Analysis$219,961
U19 · FY2014 · CA · contact PI
Chemical Synthesis, Biochemistry & Spectroscopic Analysis$233,142
U19 · FY2013 · CA · contact PI
PRODRUGS FOR ADENOVIRAL EYE INFECTIONS$115,284
R41 · FY2000 · EY